LIVER
Human hepatic stellate cell lines, LX-1 and LX-2: new tools
for analysis of hepatic fibrosis
L Xu, A Y Hui, E Albanis, M J Arthur, S M Oâ€™Byrne, W S Blaner, P Mukherjee, S L Friedman, F J Eng
...............................................................................................................................
See end of article for
authorsâ€™ affiliations
.......................
Correspondence to:
Professor S L Friedman,
Box 1123, Mount Sinai
School of Medicine, 1425
Madison Avenue, Room
11-70C, New York,
NY10029, USA;
Scott.Friedman@
mssm.edu
Revised version received
3 May 2004
Accepted for publication
25 May 2004
.......................
Gut 2005;54:142â€“151. doi: 10.1136/gut.2004.042127
Background: Hepatic stellate cells (HSCs) are a major fibrogenic cell type that contributes to collagen
accumulation during chronic liver disease. With increasing interest in developing antifibrotic therapies,
there is a need for cell lines that preserve the in vivo phenotype of human HSCs to elucidate pathways of
human hepatic fibrosis. We established and characterised two human HSC cell lines termed LX-1 and
LX-2, and compared their features with those of primary human stellate cells.
Methods and results: LX-1 and LX-2 were generated by either SV40 T antigen immortalisation (LX-1) or
spontaneous immortalisation in low serum conditions (LX-2). Both lines express a smooth muscle actin,
vimentin, and glial fibrillary acid protein, as visualised by immunocytochemistry. Similar to primary HSCs,
both lines express key receptors regulating hepatic fibrosis, including platelet derived growth factor
receptor b (bPDGF-R), obese receptor long form (Ob-RL), and discoidin domain receptor 2 (DDR2), and
also proteins involved in matrix remodelling; matrix metalloproteinase (MMP)-2, tissue inhibitor of matrix
metalloproteinase (TIMP)-2, and MT1-MMP, as determined by western analyses. LX-2 have reduced
expression of TIMP-1. LX-2, but not LX-1, proliferate in response to PDGF. Both lines express mRNAs for
a1(I) procollagen and HSP47. Transforming growth factor b1 stimulation increased their a1(I) procollagen
mRNA expression, as determined by quantitative reverse transcription-polymerase chain reaction. LX-2,
but not LX-1, cells are highly transfectable. Both lines had a retinoid phenotype typical of stellate cells.
Microarray analyses showed strong similarity in gene expression between primary HSCs and either LX-1
(98.4%) or LX-2 (98.7%), with expression of multiple neuronal genes.
Conclusions: LX-1 and LX-2 human HSC lines provide valuable new tools in the study of liver disease. Both
lines retain key features of HSCs. Two unique advantages of LX-2 are their viability in serum free media
and high transfectability.
Hepatic stellate cells (HSCs) (previously known as Ito
cells, lipocytes, or fat storing cells) are a major cell type
responsible for liver fibrosis following their activation
into fibrogenic myofibroblast-like cells.1â€“3 With accumulating
insights into stellate cell biology, there is an increasing need
for renewable cell culture models that faithfully recapitulate
their in vivo phenotype. Indeed, much of our current
knowledge of stellate cell behaviour has been gained through
animal models and primary culture studies, particularly from
the rat. When cultured on uncoated plastic, stellate cells
undergo spontaneous activation that correlates closely with
their response in vivo.4 However, it is essential to validate
mechanisms elucidated from rodent models in human
stellate cells in order to establish their relevance to human
disease.
An important limitation of using human stellate cells has
been the infrequent and unpredictable availability of human
tissue suitable for cell isolation, as well as the modest yield
and frequent impurities that characterise these isolates. One
approach to overcome these difficulties has been to passage
fibroblast-like outgrowths from whole tissue sections, which
usually represent a heterogenous mixture of activated HSCs
with other hepatic cell types, including large vessel endotheï¿¾lial cells and vascular smooth muscle cells. In addition to
their heterogeneity, the utility of explant outgrowths has
been limited by the finite number of passages the cells
undergo unless immortalised.5 Moreover, isolates from
human liver vary from prep to prep, making it difficult to
directly compare findings.
To overcome these issues of species specificity and culture
variability, and to provide a stable and unlimited source of
human HSCs that are homogenous, we have established two
new immortalised HSC cell lines, LX-1 and LX-2. These cell
lines have been extensively characterised and retain key
features of cytokine signalling, neuronal gene expression,
retinoid metabolism, and fibrogenesis, making them highly
suitable for culture based studies of human hepatic fibrosis.
METHODS
Materials
Pronase was obtained from Roche Molecular Biochemicals
(Indianapolis, Indiana, USA). Medium 199 (M 199), bovine
serum albumin (BSA), and collagenase type IV were obtained
from Sigma-Aldrich Co. (St Louis, Missouri, USA).
Dulbeccoâ€™s modified Eagleâ€™s medium (DMEM), Hamâ€™s F-12
medium, Nycodenz, and Trizol reagent were from Gibco BRL
(Grand Island, New York, USA). Penicillin-streptomycin,
fetal bovine serum, trypsin-EDTA, and L-glutamine were
purchased from Fisher (Springfield, New Jersey, USA).
Transforming growth factor b1 (TGF-b1) was from R&D
Systems Inc. (Minneapolis, Minnesota, USA).
For immunocytochemistry, monoclonal antibodies for a
smooth muscle actin (a-SMA), CD68, and factor VIII related
antigen were from Dako Corporation (Carpinteria, California,
USA). Monoclonal antibody for Simian Virus 40 large T
Abbreviations: HSC, hepatic stellate cell; PDGF, platelet derived growth
factor; bPDGF-R, PDGF receptor b; DDR2, discoidin domain receptor 2;
Ob-RL, obese receptor long form; MMP, matrix metalloproteinase; TIMP,
tissue inhibitor of matrix metalloproteinase; TGF-b1, transforming
growth factor b1; BSA, bovine serum albumin; DMEM, Dulbeccoâ€™s
modified Eagleâ€™s medium; a-SMA, a smooth muscle actin; GFAP,
antiglial fibrillary acid protein; FBS, fetal bovine serum; PBS, phosphate
buffered saline; RT-PCR, reverse transcription-polymerase chain
reaction; HPLC, high pressure liquid chromatography
142
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

antigen (SV40 T-antigen, mAb) was from Santa Cruz
Biotechnology (Santa Cruz, California, USA). Antivimentin
and antiglial fibrillary acid protein (GFAP) monoclonal
antibodies were from NeoMarkers (Fremont, California,
USA). Antirabbit IgG fluorescein and antimouse IgG (H+L)
Texas Red were purchased from Vector Laboratories Inc.
(Burligame, California, USA). DAPI was obtained from
Molecular Probes (Eugene, Oregon, USA).
For western analysis, antibody for discoidin domain
receptor 2 (DDR2; R2-JM) was described previously.6 The
obese receptor long form (Ob-RL) antibody (H300) was
obtained from Santa Cruz Biotechnology, matrix metalloproï¿¾teinase (MMP)-2 antibody was from Sigma-Aldrich, and
MT1-MMP, tissue inhibitor of matrix metalloproteinase
(TIMP)-1, and TIMP-2 were obtained from Chemicon
(Temecula, California, USA). A monoclonal antibody for
the platelet derived growth factor receptor b (bPDGF-R)
was from Transduction Laboratories (Newington, New
Hampshire, USA).
HSC isolation and culture
HSCs were isolated as previously described.7 Isolated HSCs
were cultured in M199 containing 10% fetal bovine serum
(FBS) 24 hours later and every 3â€“4 days thereafter. When the
cultures reached confluence, they were trypsinised (0.05%
trypsin/0.53 mM EDTA) and passaged at a ratio of 1:3.
Subsequent passages were performed every 7â€“10 days.
Transfection and immortalisation
HSCs subcultured to passage 3 were trypsinised and plated at
a density of approximately 40% confluence in a 10 cm dish.
The following day, the passage 4 cells were transfected with
the plasmid pRSVTag that encodes the SV40 large T antigen
under the control of a rous sarcoma virus (RSV) promoter.
Plasmid DNA (10 mg) was mixed with 30 ml of Fugene
(Roche) in 1 ml of serum free media for 15 minutes and then
added to the HSC culture that was maintained in 4 ml of
fresh M199 media containing 10% FBS. The transfection
media were removed 24 hours later and replaced with M199
media containing 10% FBS after the cultures were washed
three times with phosphate buffered saline (PBS) to remove
any residual Fugene reagent. The culture was subsequently
passaged seven times at which point the cells appeared
morphologically distinct from normal passaged cells and
were also more proliferative. The LX-1 cell line was
established from an individual clone from the primary T
antigen immortalised cultures. The LX-2 cell line was
established by selecting for a subline of the LX-1 cells that
was able to grow under reduced serum conditions (1% FBS).
A single clone from the outgrowth was expanded and
designated LX-2. The LX-2 cell line was cultured in DMEM
with only 2% FBS. The LX-1 cell line was cultured in DMEM
with 10% FBS.
To determine the transfection efficiency of LX-2 cells,
2.5 mg of a plasmid expressing enhanced green fluorescent
protein pEGFP-C2 (Clontech, Palo Alto, California, USA) was
mixed with 7.5 ml of Fugene in 0.25 ml serum free media for
15 minutes. This mixture was added to LX-2 cells cultured on
six well dishes with 2 ml DMEM containing 2% FBS. Cells
were visualised with an inverted microscope for bright field
and green fluorescence images
Immunocytochemistry
Cells were plated on glass coverslips (Fisher Scientific) in
12 well culture dishes and grown to approximately 50%
confluence for three days to promote the adherence of cells.
Cells were then washed twice with cold serum free media
(DMEM) and then fixed in 4% paraformaldehyde in PBS for
10 minutes. After fixation, cells were washed twice with PBS
and then permeabilised with PBS containing 0.1% Triton
X-100 for 15 minutes. They were next washed twice with PBS
and incubated with blocking solution (5% BSA in PBS) for
30 minutes. Primary antibodies (diluted 1:100 in blocking
solution) were incubated with the cells for one hour. After
three washes with PBST (0.2% Tween 20 in PBS), cells were
incubated with fluorescein labelled antimouse IgG (Vector
Laboratories; diluted 1:200 in blocking buffer) for one hour.
Cells were washed three times with PBST and then stained
with DAPI (Molecular Probes; 1:5000 in PBS) for one minute,
washed three times with PBST and then twice with PBS. Cells
were viewed with a Nikon Eclipse E600 fluorescence
microscope.
Protein analysis
HSCs and LX-1 cells were cultured in DMEM/10% FBS. LX-2
cells were cultured in DMEM/2% FBS. Cells grown in 10 cm
dishes were washed three times with cold PBS and harvested
in 0.4 ml of cold lysis buffer (20 mM Tris 7.4, 150 mM NaCl,
1% TX-100) with protease inhibitors (Complete, EDTA free;
Roche) sonicated, and centrifuged. The supernatant was
measured for protein concentration (DC Protein Assay;
Biorad, Hercules, California, USA). Samples were adjusted
to 16Laemmli loading buffer and 30 mg of the samples were
subjected to 10% sodium dodecyl sulphate-polyacrylamide
gel electrophoresis and then transferred to nitrocellulose.
Membranes were blocked and washed in TBS Tween buffer
and then developed with Western Lightning Plus (Perkin
Elmer, Boston, Massachusetts, USA).
For the detection of bPDGF-R, lysates were first immunoï¿¾precipitated with a monoclonal antibody for bPDGF-R prior
to western blotting. For immunoprecipitation, cells from a
10 cm dish were harvested with 1 ml of cold lysis buffer.
Cleared lysates were incubated with antibody and protein G
sepharose (UltraLink; Pierce, Rockford, Illinois, USA) overï¿¾night at 4ËšC. After washing three times with lysis buffer, the
resin was eluted by resuspension in 16 Laemmli loading
buffer and boiling for 10 minutes. To determine the
gelatinase (MMP-2) activity secreted by LX-2 cells, gelatin
zymography was performed as previously described.8
Comparative quantitative real time RT-PCR
HSCs, LX-1 and LX-2 cells were plated in 60 mm diameter
dishes and cultured to 70% confluence. Cells were serum
starved and supplemented with 0.2% BSA for 48 hours prior
to TGF-b1 treatment (2.5 ng/ml for 20 hours). LX-1 cells
were additionally supplemented with 0.5% FBS. Control cells
were also serum starved. Total RNA was extracted with
TRIzol reagent (Invitrogen, Carlsbad, California, USA)
according to the manufacturerâ€™s instructions. Briefly, cells
were lysed with the reagent, chloroform was added, and
cellular RNA was precipitated by isopropyl alcohol. After
washing with 75% ethanol, the RNA pellet was dissolved in
nuclease free water.
Total RNA was reverse transcribed to complementary DNA
(cDNA) using the Reverse Transcription System (Promega,
Madison, Wisconsin, USA). RNA (1 mg) in 7.7 ml of nuclease
free water was added to 2.5 ml of 106 reverse transcriptase
buffer, 10 ml of 25 mM MgCl2, 2.5 ml of 10 mM dNTP, 1.0 ml
of random primer, 0.5 ml of RNase inhibitor, and 0.8 ml of
AMV reverse transcriptase in a total volume of 25 ml. The
reaction was performed for 10 minutes at 25ËšC (annealing),
60 minutes at 42ËšC (cDNA synthesis), and five minutes at
95ËšC (enzyme denaturation).
Comparative quantitative real time polymerase chain
reaction (PCR) was performed with an ABI Prism 7700
Sequence Detection System (Applied Biosystems, Foster City,
California, USA). cDNA (1 ml) was used in each PCR reaction.
The housekeeping gene b-actin was used as a reference gene
Human HSC lines, LX-1 and LX-2 143
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

for normalisation and H2O was used as a negative control.
The primer pairs (sense/antisense) for a1(I) procollagen were
59-AAC ATG ACC AAA AAC CAA AAG TG-39 and 59-CAT TGT
TTC CTG TGT CTT CTG G-39; for HSP47: 59-ATG AGA AAT
TCC ACC ACA AGA TG-39 and 59GAT CTT CAG CTG CTC TTT
GGT TA-39; and for b-actin: 59-GAT GAG ATT GGC ATG GCT
TT-39 and 59-GAG AAG TGG GGT GGC TT-39. The PCR
reaction was catalysed by Platinum Taq polymerase
(Invitrogen) while SYBR Green I DNA binding dye
(Molecular Probes) generated the fluorescence signals during
each of the 40 cycles, in proportion to the quantities of double
stranded DNA (denaturation 15 seconds at 95ËšC; annealing
15 seconds at 56ËšC; and extension 40 seconds at 72ËšC).
Analysis of the PCR products by agarose gel electrophoresis
confirmed the specificity of the PCR reaction and the
homogeneity of the DNA products.
Cell proliferation assay
LX-2 cells were assayed for their proliferative response to BBï¿¾PDGF stimulation in serum free conditions by [3
H] thymiï¿¾dine incorporation, as previously described.9
Analysis of retinoid biology
Retinol uptake and processing by LX-1 and LX-2 cells
Following plating and overnight incubation, cells were
treated with two different concentrations (2 mM and
10 mM) of retinol for 24 hours in the dark. For this purpose,
a concentrated stock solution of retinol was diluted in a small
volume of ethanol (,1% of the aqueous volume), added to
the media with 300 mM palmitic acid to aid esterification,
and then vigorously mixed. Following incubation, media
from triplicate cultures were removed and cells scraped into
2 ml of ice cold PBS. Samples were then stored at 220ËšC prior
to analysis. Control cells were cultured in medium with
ethanol vehicle.
HPLC analyses of retinol and retinyl esters
Retinol and retinyl esters were analysed by reversed
phase high pressure liquid chromatography (HPLC), as
described by Yamada and colleagues,10 using a Waters 510
HPLC pump (Waters Associates, Milford, Massachusetts,
USA) operating at a flow of 1.8 ml/min, an Ultrasphere C18
column (5 mm; 4.6 mm625 cm) (Beckman Instruments,
Fullerton, California, USA), and a Waters 996 Photodiodeï¿¾array detector. Retinol and retinyl esters were monitored at
325 nm and quantified using standard curves relating the
known mass to mass ratio of retinol or retinyl esters to that of
internal standard retinyl acetate. This HPLC method allows
for detection and quantitation of different retinyl esters,
including retinyl palmitate, oleate, stearate, linoleate, and
myristate.
Microarray analyses
RNA preparation
RNA was extracted from HSC and LX cells grown to
80% confluence in DMEM containing 10% FBS using
Qiagen (Valencia, California, USA) RNeasy column with
on-column DNase treatment. RNA was eluted in RNase-free
water, and A260/A280 ratios were .2.0. The integrity of
the total RNA was verified by denaturing agarose gel
electrophoresis (NorthernMax-Gly; Ambion, Austin Texas,
USA).
Biotin labelled cRNA (target) preparation
For cDNA synthesis, 5 mg of total RNA were mixed with a T7
primer and Superscript II reverse transcriptase (Invitrogen)
and incubated at 42ËšC for one hour. The second strand of
cDNA was generated by mixing the first strand with
Escherichia coli DNA polymerase I and RNase H, and
incubating at 16ËšC for two hours. The double stranded
cDNA was purified by the QIAquick kit (Qiagen), according
to the manufacturerâ€™s protocol. Purified cDNA was eluted
in 10 mM Tris-HCl, pH 8.5, and dried in a Speed-Vac. For
cRNA synthesis, purified cDNA was incubated with biotin
labelled 11-UTP and 11-CTP in an overnight in vitro transï¿¾cription reaction at 37ËšC. RNA was purified and recovered
by Rneasy column purification (Qiagen) following the
manufacturerâ€™s protocol. RNA was eluted in RNase free
water and quantified by UV spectrophotometry at 260 nm.
The size distribution of the biotin labelled cRNA was verified
on a Bioanalyzer (Agilent, Foster City, California, USA), and
ranged from 500 to 2000 nucleotides in length (data not
shown). The average yield of cRNA was approximately
100 mg per reaction. Biotin labelled cRNA was fragmented
by heating at 94ËšC for 20 minutes in the presence of magneï¿¾sium, yielding fragments approximately 50â€“200 nucleotides
in length.
Hybridisation and processing
Fragmented biotin labelled cRNA (10 mg) was mixed with
the CodeLink hybridisation buffer (260 ml total volume) and
injected into replicate (2) CodeLink UniSet Human I
bioarrays. Arrays were loaded onto a tray and hybridised
overnight at 37ËšC shaking at 300 RPM in an Innova
incubator. Arrays were rinsed individually and then placed
in a stringency wash for one hour. Next, each slide was
incubated in 3.4 ml of streptavidin-Alexa 647 (Molecular
Probes) working solution for 30 minutes, after which the
slides were washed four times in 240 ml of TNT buffer. For
the final washes, slides were rinsed twice in 240 ml of
reagent grade water. The slides were then dried with an N2
gas stream.
Data collection and image analysis
Spot detection was performed with the GenePix Series A
scanner (Axon Instruments, Foster City, California, USA)
and spot quantitation was performed using the CodeLink
software. Key quantitation parameters are briefly described
here: local background subtraction is carried out on
individual spot intensities, followed by a scaling of each
array individually based on the overall array intensity. After
median normalisation, the negative control threshold is
calculated using a set of negative control probes, as described
previously.11 12
Statistical analysis
The normalised dataset was filtered to exclude clones with
intensities below the negative threshold value for each array.
Array experiments for each cell line were then further filtered
to exclude clones that were differentially expressed greater
than 1.5-fold between the two technical replicates. Intensities
were averaged across technical replicates for each clone, and
the SNOMAD (Standardisation and NOrmalisation of
MicroArray Data) gene expression data analysis tool (availï¿¾able at http://pevsnerlab.kennedykrieger.org/snomadinput.
html) was used to standardise the array data for pairs of
cell lines in order to render them more comparable. Briefly,
the datasets were log transformed and the R â€˜â€˜lowessâ€™â€™
function was used to correct for mean local variance. Finally,
z scores (that is, standard deviation units relative to the
amount of variance in the log values at particular expression
levels) were calculated for each clone.13 Clones with z
scores greater than 5 or less than 25 and with expression
ratios greater than fivefold were considered differentially
expressed. Several differentially expressed clones were
validated using comparative quantitative reverse transcripï¿¾tion (RT)-PCR.
144 Xu, Hui, Albanis, et al
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

RESULTS
Isolation and immortalisation of human hepatic
stellate cells
HSCs were obtained from a ,15 g wedge of normal liver
tissue by collagenase/pronase treatment followed by fractionï¿¾ation on a Nycodenz density gradient to isolate the bouyant
and lipid rich stellate cells, as described in the methods
section. The primary culture isolate was plated onto an
uncoated plastic dish, trypsinised after three days, and
subcultured. These cells were passaged three more times in
order to remove potential contaminating hepatocytes, endoï¿¾thelial cells, and Kupffer cells, which typically do not survive
trypsinisation and subculturing. These passage 4 HSCs were
then examined by immunocytochemistry for a-SMA, a
marker for activated HSCs, to assess their purity. All cells
were positive for a-SMA whereas there was no immunoï¿¾staining for CD68 or factor VIII related antigen, which are
markers for Kupffer and endothelial cells, respectively.
Positive control immunostaining for CD68 and factor VIII
related antigen in isolated Kupffer cells and endothelial cells
confirmed the specificity of these markers (data not shown).
For immortalisation, a culture of the passage 4 cells was
transfected with the plasmid pRSV-Tag that expresses the
SV40 large T antigen under the control of a rous sarcoma
virus promoter. To select for the immortalised cells, we took
into account that primary passaged HSCs are viable for only a
limited number of passages, and furthermore that they
replicate slowly with a doubling time of approximately seven
days. We further assumed that the immortalised cells would
grow more rapidly than the primary passaged HSCs from
which they derived as the SV40 large T antigen is capable of
inhibiting G1 cell cycle growth arrest (reviewed by Ali and
DeCaprio14). The T antigen transfected culture was subculï¿¾tured at a 1:10 dilution for several passages with the expecï¿¾tation that immortalised cells would eventually dominate the
culture population. After seven rounds of passaging, there
was a noticeable morphological change in the culture. The
cells were smaller in size, appearing less outstretched, and
the proliferation rate markedly increased, with a culture
doubling time of only 24 hours. By limiting dilution, single
cell clones were isolated and amplified. One clone designated
LX-1 was expanded for further investigation.
Another immortalised HSC cell line designated LX-2 was
established by applying the selection pressure of growing a
subset of early passaged LX-1 cells in reduced serum (1%
FBS). The rationale was to establish a cell line that remained
viable in the absence of serum growth factor support,
characteristic of primary HSCs. Four separate pools of early
passage LX-1 cells were grown in reduced serum, and nearly
all of the cells detached from the culture dishes after a single
day. Three days later, the remaining cells in the culture were
reincubated in growth factor rich media (10% fetal bovine
serum) for several weeks until they reached confluence, and
were then subjected to growth in reduced serum again. After
four sequential rounds of this selection procedure, we
identified in one out of four original pools a culture of cells
which grew stably in 1% FBS. These cells appeared
morphologically homogenous and proliferated slowly regardï¿¾less of the serum concentration, with a culture doubling time
of approximately 3â€“4 days. The LX-2 cell line has since been
maintained and expanded in low serum media for up to 50
passages.
To determine if the cell lines expressed the SV40 large T
antigen, they were analysed by immunocytochemistry (fig 1).
SV40 large T antigen was mostly localised in the nucleus of
the LX-1 cells, whereas the LX-2 cells were negative,
indicating the loss of T antigen expression (fig 1). Western
analysis confirmed this finding (data not shown). As a
control, cells were costained with DAPI to identify the nuclei
(fig 1).
Figure 1 Expression of SV40 large T antigen (TAg) in the LX-1 cell line. LX cells were subjected to immunocytochemical analysis (see methods). The
SV40 large T antigen was detected in the nucleus of LX-1 cells but not in LX-2 cells. Cells were costained with DAPI to identify nuclei.
Human HSC lines, LX-1 and LX-2 145
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

Expression of intermediate filaments
Cell lines were also examined by immunocytochemistry for
expression of the intermediate filament proteins a-SMA,
vimentin, and GFAP, which are typically expressed in HSCs
(fig 2). Both LX-1 and LX-2 cells expressed a-SMA, a marker
for activated HSCs. Vimentin, a marker for cell types of
mesenchymal origin, and GFAP, a marker of a subpopulation
of stellate cells, were present in both cell lines in a
cytoskeletal network. Western analysis also confirmed
expression of these proteins (data not shown).
Expression of receptors: PDGF-R, OB-RL , and DDR2
The most potent mitogen towards activated HSCs is PDGF
which is a dimer of two polypeptide chains, the A and B
chains. Of the three possible dimeric forms (AA, AB, and BB),
BB-PDGF, is most potent in stimulating HSC proliferation
and migration, consistent with predominant expression of
the PDGF receptor b subunit, which responds preferentially
to PDGF B chain.15 Both LX cell lines expressed the bPDGF-R
subunit, which comigrated with the b subunit of the PDGF
receptor expressed by primary human HSCs and with the
higher molecular weight form expressed in NIH3T3 cells
(fig 3). This finding suggests that the cell lines represent
activated HSCs since the PDGF-R b subunit is not expressed
in quiescent cells.9 15 Although both cell lines expressed
bPDGF-R, stimulation with BB-PDGF ligand increased
proliferation of only LX-2 (fig 3) but not LX-1 in serum free
medium (data not shown), as determined by 3
H-thymidine
incorporation.
In addition to the PDGF receptor, we identified two other
receptors, DDR2 and Ob-RL, in both LX lines (fig 4). DDR2 is
a receptor tyrosine that we previously documented in rat
stellate cells.6 16 Human HSCs express DDR2, as determined
by western blot (fig 4). The DDR2 protein appeared as a
doublet from both cell lines whereas primary HSCs primarily
expressed the higher molecular weight species only. The
lower band may represent a form of the receptor that is not
tyrosine phosphorylated, as we have previously documented
in rat HSCs.6 16
Western blot also demonstrated expression of an approxiï¿¾mately 200 kDa Ob-RL protein in human HSCs and in the cell
lines (fig 4). Signalling through Ob-RL, the long and
signalling competent isoform of the leptin receptor, enhances
the fibrogenic response of rodent HSCs.17â€“19 Moreover, a
recent study from our laboratory has documented expression
of Ob-RL protein in rat HSCs.19
Matrix remodelling proteins: MMP-2, MT1-MMP,
TIMP-1, and TIMP-2
Expression of matrix metalloproteinases (MMPs) and their
tissue inhibitors (TIMPs) are increased in liver fibrosis and
contribute to both the progression and regression of fibrosis.20
Figure 2 Expression of intermediate filaments by LX-1 and LX-2. LX cells were subjected to immunocytochemical analysis (see methods). Both LX-1 and
LX-2 cells expressed and formed a cytoskeletal network of a-smooth muscle actin (a-SMA), vimentin, and glial fibrillary acid protein (GFAP). Cells were
costained with DAPI to identify nuclei.
146 Xu, Hui, Albanis, et al
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

MMP-2 (also known as gelatinase A) is expressed and
secreted by HSCs as they become activated in culture.21
MMP-2 proteinase activity is regulated at the cell surface
and involves the formation of a tri-molecular complex
that associates pro-MMP2 with MT1-MMP (also known as
MMP-14) and TIMP-2. All three components of this complex
are expressed by activated HSCs.
We examined LX-1 and LX-2 cell lines for expression of
this tri-molecular protein complex which regulates MMP-2
activity. Western analysis of whole cell lysates demonstrated
all three components (figs 4, 5). However, for MMP-2, both
the pro- and active forms were both detected in primary HSCs
whereas mostly the pro-MMP2 form was detected in both LX
cell lines. Secretion of MMP-2 by LX-2 cells was also
evaluated but could not be assessed in LX-1 cells as they
underwent rapid cell death in the serum free conditions
required to determine MMP-2 secretion (serum contains
large amounts of MMP-2). LX-2 cultures were serum starved
for 16 hours and the harvested conditioned media were
subjected to gelatin zymography. This method of analysis can
detect gelatinase activity, even of proenzymes, due to sodium
dodecyl sulphate induced protein conformational changes
that reveal latent activities. Gelatinase activity was detected
which corresponds to the higher molecular weight form (proï¿¾MMP-2) detected by western blot (fig 5).
Expression of TIMP-1 protein, which inhibits collagen
degradation, was also evaluated. Both TIMP-1 and TIMP-2
expression increase dramatically as HSCs become activated in
culture. In contrast with LX-1 and primary HSCs, LX-2 cells
expressed only a small amount of TIMP-1 protein (fig 4).
However, we only examined TIMP expression in cell lysates,
and as TIMPs are usually secreted, there may be a
considerable amount in the culture media. For TIMP-2, its
detection in cell lysates may be due to its association with
MT1-MMP at the cell surface. It is unclear why TIMP-1 is
abundant in HSC and LX-1 cell lysates, but not in those of
LX-2 cells (fig 4). However, TIMP-1 production in LX-2 was
stimulated in response to leptin, a profibrogenic hormone in
the liver.22
Expression of a1(I) procollagen and HSP47 mRNA
To evaluate the ability of the cell lines to produce fibrillar type
I collagen that is associated with fibrosis, comparative
quantitative real time RT-PCR was performed for a1(I)
procollagen and HSP47 mRNAs. HSP47 is a collagen specific
chaperone protein that is required for collagen biosynthesis
and is involved in procollagen processing, maturation, and
secretion.23 HSP47 mRNA is expressed in human HSCs and in
the LX-1 and LX-2 cell lines, with 50% greater expression in
LX-1 than LX-2. LX cells also expressed much more HSP47
mRNA than the hepatoma cell lines Huh7 and HepG2, which
were used as a negative control (fig 6). Expression of a1(I)
procollagen paralleled the level of HSP47 expression across
primary HSCs and LX cell lines (fig 6).
TGF-b1 stimulates a(1)I procollagen mRNA in LX cell
lines
TGF-b1 is a potent profibrogenic cytokine of primary HSCs
that stimulates expression of a(1)I procollagen mRNA. TGFï¿¾b1 treatment of LX-1 and LX-2 cells increased expression of
a1(I) procollagen mRNA by 3â€“4-fold, as assessed by
comparative real time RT-PCR (fig 7).








	



 
  !"#$
	 %&'
!'( ( )* + !"#$
!"#$
	 %&'
Î²!"#$,
-.


/
)*	
-.


/
)*
Figure 3 Expression of the platelet derived growth factor receptor b
(bPDGF-R) and response of LX-2 cells to BB-PDGF. (Top) Immunoï¿¾precipitation/western analysis (see methods) detected expression of the
bPDGF-R subunit in both LX-1 and LX-2 cells. NIH3T3 cells and
passaged human hepatic stellate cells (HSC) were used as controls.
(Bottom) BB-PDGF ligand (1 and 10 ng/ml) stimulated proliferation of
LX-2 cells in serum free medium, as determined by 3
H-thymidine
incorporation (cpm).


	




  
Figure 4 Expression of receptors and matrix remodelling proteins
detected by western analyses. LX cell lines and primary passaged
hepatic stellate cells (HSC) were compared side by side for their
expression of the receptors discoidin domain receptor 2 (DDR2) and
obese receptor long form (Ob-RL), and also for the matrix remodelling
proteins MT1-MMP, tissue inhibitor of matrix metalloproteinase (TIMP)-2
and TIMP-1 (see methods): 40 mg of protein from cell lysates were
loaded per sample.
Figure 5 Matrix metalloproteinase (MMP)-2 protein expression and
activity. (Top) Western analysis detected the pro- and active form of
MMP-2 in primary hepatic stellate cells. In LX cells, pro-MMP-2 was
mostly detected: 40 mg of protein from cell lysates were loaded per
sample. (Bottom) Gelatin zymography of conditioned media from LX-2
cells indicated secretion of pro-MMP2.
Human HSC lines, LX-1 and LX-2 147
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

LX-2 cells are highly transfectable
A major technical limitation to studying cultured stellate cells
has been their consistently very low transfection efficiency,
typically less than 1%. This has imposed significant limitaï¿¾tions in the study of this cell type, as molecular genetic
manipulation by ectopic overexpression of genes (and
dominant negatives thereof) could not be performed. Viral
infection of HSCs has been reported24 25 but is time consumï¿¾ing. In contrast, LX-2 cells displayed a relatively high
transfection efficiency of .30% using a commercial reagent,
Fugene (fig 8). LX-1 and primary human HSCs displayed
,1% efficiency with Fugene (data not shown).
LX-1 and LX-2 cell lines metabolise retinoids
LX-1 and LX-2 stellate cells were analysed for their ability to
take up and esterify retinol (2 mM and 10 mM). In untreated
cells, no retinyl esters and only very low levels of retinol could
be detected. (Concentration of retinol in medium containing
10% FBS is approximately 0.1 mM, which is well below the
physiological concentration of retinol (2 mM).) As depicted in
fig 9, both retinol and retinyl esters accumulated in LX-1 and
LX-2 stellate cells on retinol incubation, which was greater at
higher concentrations of added retinol. Both cell lines
accumulated retinol and converted it to retinyl ester to a
similar extent. Retinyl esters were present only intracellularly
and none could be detected in the medium. Thus retinoid
metabolism by LX-1 and LX-2 lines is similar to that reported
in rat liver stellate cells.26
Gene expression analysis of LX-1 and LX-2 cell lines
by microarray compared with primary HSCs
To achieve a more global characterisation of gene expression
by LX-1 and LX-2, we compared their mRNA profiles to
primary HSCs by microarray analysis using Amersham
Codelink to scan approximately 10 000 gene probes (clones).
Of the 2211 clones detected with expression above negative
thresholds for both LX-1 and primary HSCs, 36 were
differentially expressed (98.4% similarly expressed), and of
the 2240 clones detected with expression above negative


	
 	
  








 
 


	
 	
  









 
!
Figure 6 HSP47 (A) and a1(I) procollagen (B) mRNA expression.
Primary hepatic stellate cells (HSC), LX cells, and the hepatoma cells
Huh7 and HepG2 were examined and compared for their expression of
HSP47 (A) and a1(I) procollagen (B) mRNA. using quantitative real time
reverse transcription-polymerase chain reaction (see methods).
Expression levels of primary HSC were used as a reference point set at 1
and the fold differences are indicated. Error bars represent mean (SEM)
(n = 3). All cells were cultured in Dulbeccoâ€™s modified Eagleâ€™s medium
(DMEM)/10% fetal bovine serum (FBS) except for LX-2 cells which were
cultured in DMEM with only 1% FBS.
	
 Î²








 
	
 Î²












 
	
 Î²













 
Figure 7 Transforming growth factor b1 (TGF-b1) increases a1(I)
procollagen mRNA in hepatic stellate cells (HSC) (A), and LX-1 (B) and
LX-2 (C) cells. Primary HSCs and LX cells were examined for their
responsiveness to TGF-b1, as measured by its effects on a1(I)
procollagen mRNA levels using quantitative real time reverse
transcription-polymerase chain reaction (see methods). Untreated
controls were used as a reference point set at 1 and the fold induction
after TGF-b1 treatment (2.5 ng/ml for 20 hours) is shown. Error bars
represent mean (SEM) (n = 3).
 
Figure 8 Transfection efficiency of LX-2 cells. LX-2 cells plated to 80%
confluence in six well culture dishes were transfected with Fugene and
2.5 mg of pEGFP-C2 (Clontech), a plasmid that expresses enhanced
green fluorescent protein. (A) Bright field image of transfected LX-2 cells.
(B) Fluorescence image of the same field of cells.
148 Xu, Hui, Albanis, et al
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

thresholds for both LX-2 and primary HSCs, 28 were
differentially expressed (98.7% similarly expressed). Of the
2692 clones expressed above negative thresholds for both
LX-1 and LX-2 cell lines, 18 were differentially expressed
(99.3% similarly expressed). Therefore, there were even fewer
differentially expressed genes between the two LX cell lines.
Eighteen genes were similarly differentially expressed in
both LX-1 and LX-2 when compared with primary HSCs
(tables 1â€“3). Both LX-1 and LX-2 cell lines showed reduced
expression of p21, as might be expected given their
immortalised phenotype, which was confirmed by real time
PCR (not shown). Also consistent with an immortalised
phenotype is the increased expression of CDC2, thymidine
kinase 1, TGF-bI induced 68 kDa protein, CSE1L (chromoï¿¾some segregation 1-like), and survivin, all of which have
been shown to either promote proliferation or are antiapopï¿¾totic. Differential expression of these genes is not simply a
consequence of T antigen overexpression as LX-2 cells do not
express T antigen. Both LX cell lines also had reduced
expression of LTBP2 (latent TGF-b binding protein 2) and
ITGA7 (integrin alpha 7).
Genes that are specifically differentially expressed in LX-1
compared with primary HSCs include PIG11 (p53 induced
gene 11), CTGF (connective tissue growth factor), and
decorin (tables 1â€“3). Reduced expression of PIG11 in LX-1
is consistent with inactivation of p53 by T antigen. Genes that
are specifically differentially expressed in LX-2 cells include
the oxytocin receptor and follistatin-like 1.
Increasing evidence points to a neuronal phenotype of
hepatic stellate cells.27 Indeed, a large number of neuronal
related genes were expressed in primary human stellate cells
as well as in LX-1 and LX-2 cells (table 4).
DISCUSSION
We established two human hepatic stellate cell lines and
characterised their global gene expression by microarray.
These cell lines provide important tools to study mechanisms
of hepatic fibrogenesis and the testing of antifibrotic
compounds. LX-1 cells express SV40 large T antigen whereas
LX-2 cells are immortalised without sustained T antigen;
both are stable for at least 50 passages thus far. The
phenotype of both LX lines is most similar to that of
â€˜â€˜activatedâ€™â€™ cells in vivo. For example, expression of GFAP by







	


 Âµ

 
   Âµ
	

 





 Âµ

 
   Âµ
	

 








	
	

Figure 9 LX-1 and LX-2 cells accumulate and esterify retinol. LX-1 (A)
and LX-2 (B) cell culture media were supplemented with 0 (control), 2, or
10 mM retinol for 24 hours. Cells were then washed with ice cold
phosphate buffered saline and harvested. Cell levels of retinol and retinyl
esters were measured by high pressure liquid chromatography, as
described in the methods section.
Table 1 Differential gene expression by LX-1 and LX-2
cell lines compared with primary hepatic stellate cells
(HSCs): genes similarly expressed in LX-1 and LX-2 but
differentially expressed in comparison with primary HSCs
q NM_014501 Ubiquitin carrier protein (E2-EPF)
q NM_001316 Chromosome segregation 1 (CSE1L)
q NM_005496 Chromosome associated polypeptide C (CAP-C)
q NM_006342 Transforming, acidic coiled-coil containing protein 3
q NM_014791 Maternal embryonic leucine zipper kinase
q NM_000358 Transforming growth factor b induced (TGFBI)
q NM_004221 Natural killer cell transcript 4 (NK4)
q NM_001786 Cell division cycle 2 (CDC2)
q NM_003752 Eukaryotic translation initiation factor 3, subunit 8
q NM_014390 EBNA-2 co-activator
q NM_001168 Baculoviral IAP repeat containing 5 (survivin) (BIRC5)
q NM_003258 Thymidine kinase 1 (TK1)
q NM_018131 Unknown
q NM_031299 Unknown
Q AK026920 Unknown
Q NM_000389 Cyclin dependent kinase inhibitor 1A (P 21, CIP1)
Q NM_000428 Latent transforming growth factor b binding protein 2
(LTBP2)
Q NM_002206 Integrin, alpha 7 (ITGA7)
DNA microarray analyses of LX-1 cells versus primary HSCs and of LX-2
cells versus primary HSCs were performed as described in the methods
section. The resulting datasets were normalised and compared pairwise
using the SNOMAD (Standardisation and NOrmalisation of MicroArray
Data) gene expression data analysis tool available at http://
pevsnerlab.kennedykrieger.org/snomadinput.html.12 Genes with z
scores .5 or (5 and expression ratios greater than fivefold were
considered differentially expressed. A selection of genes that were
differentially expressed in the cell lines when compared with primary
HSCs are listed (upregulated genes (q); downregulated genes (Q)).
Designations (â€˜â€˜NM_â€™â€™) refer to GenBank accession numbers.
Table 2 Differential gene expression by LX-1 and LX-2
cell lines compared with primary hepatic stellate cells
(HSC)s: genes differentially expressed only in LX-1
compared with primary HSCs
q NM_031844 Heterogeneous nuclear ribonucleoprotein
q NM_001813 Centromere protein E (CENPE)
q NM_017458 Major vault protein (MVP)
q NM_001070 Tubulin, gamma 1 (TUBG1)
q NM_021947 Serine racemase (SRR)
q NM_017613 Downstream neighbour of SON (DONSON)
q NM_006397 Ribonuclease HI, large subunit (RNASEHI)
q NM_005110 Glutamine-fructose-6-phosphate transaminase 2
(GFPT2)
q NM_004077 Citrate synthase (CS)
q AB014599 Unknown
Q NM_023037 Unknown
Q NM_001920 Decorin (DCN)
Q NM_004624 Vasoactive intestinal peptide receptor 1 (VIPR1)
Q NM_006034 P53 induced protein (PIG11)
Q NM_001901 Connective tissue growth factor (CTGF)
Q NM_002373 Microtubule associated protein 1A (MAP1A)
Q NM_020404 Tumour endothelial marker 1 precursor (TEM1)
Q NM_002514 Nephroblastoma overexpressed gene (NOV)
See footnote to table 1.
Human HSC lines, LX-1 and LX-2 149
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

LX lines is more typical of chronic liver disease in which both
HSCs and portal myofibroblasts express this intermediate
filament28 whereas in normal liver the majority of human
HSCs are not immunoreactive for this intermediate filaï¿¾ment.29 In addition to GFAP, LX cells express the receptors
bPDGF-R, DDR2, and Ob-RL that are expressed in activated
HSCs but not in quiescent cells. Despite this activated
phenotype, LX-1 and LX-2 lines can be quiesced by growth
in matrigel (not shown) or low serum30 which is similar to
results that we have reported for an immortalised rat stellate
cell line HSC-T6.15
Both cell lines express the b subunit of the PDGF receptor
but only the LX-2 cells are responsive to BB-PDGF induced
proliferation. One potential explanation for this insensitivity
in LX-1 is that the cells are already maximally stimulated by
either serum derived or autocrine PDGF. Similar to primary
activated HSCs, LX-2 cells remain viable in serum free
medium with 0.2% BSA in contrast with LX-1 cells. LX-1 and
LX-2 cells are responsive to TGF-b1, a major fibrogenic
cytokine in liver disease. TGF-b1 is increased in animal
models of liver fibrosis and in patients with chronic liver
disease.31 32
HSCs have been characterised by their expression of
specific marker genes, yet in vivo there is considerable
heterogeneity and plasticity of their phenotype.28 29 33â€“35 Such
heterogeneous patterns of expression are likely to reflect local
influences of the microenvironment that include extracellular
matrix, soluble autocrine and paracrine factors, and cell-cell
communication.
Established cell lines will, by definition, differ to some
extent in their molecular phenotype from cultured primary
cells as they are immortal. Of the three other human stellate
cell lines (besides LX-1 and LX-2) described to date, only the
hTERT-HSC cell line is derived from density gradient purified
HSCs, similar to the LX lines. The hTERT-HSC cell line was
developed by immortalisation with retroviral expression of
human telomerase.5 Interestingly, like LX cells, the hTERTï¿¾HSC cell line expresses GFAP which is also expressed by a
majority but not all activated human HSCs in vivo. The two
other human stellate cell lines represent spontaneous outï¿¾growths from diseased livers: the LI90 cell line was derived
from an outgrowth of a hepatic mesenchymal tumour36 and
the GREF-X cell line was obtained by spontaneous immortaï¿¾lisation of cultured liver myofibroblasts from a cirrhotic liver
explant outgrowth.37 Importantly, of all human stellate cell
lines generated to date, only the LX-2 cell line remains viable
in the absence of serum. In addition to validating fibrogenic
pathways in LX-1 and LX-2 cells, we have also demonstrated
that the LX cell lines express the components of a matrix
degrading complex. Specifically, they express the gelatinase A
matrix remodelling complex, comprised of pro-MMP-2, MT1-
MMP, and TIMP-2. Moreover, LX-2 cells secrete pro-MMP2,
making them an important potential tool for exploring
matrix degradative pathways in a human cell model.
Recently, LX-2 cells were shown to be migratory due to
increased MMP-2 activity from cytokine stimulation.38
Increasing evidence also links matrix degradation directly
to apoptosis in stellate cells,39 and the unique capacity of LX-2
cells to withstand serum deprivation not only provides a
means to assay MMP-2 by zymography without the
confounding effects of serum but also to explore pathways
of apoptosis. Recently, LX-2 cells were shown to be capable of
undergoing TRAIL mediated apoptosis, as do primary HSCs.30
A unique advantage of LX-2 cells is their relative high
transfectability, with efficiencies of transfection of ,30%
using commercial reagents (Fugene), compared with efficï¿¾iencies of less than 1% for LX-1 cells and all other stellate cell
culture systems reported to date.
The microarray analysis also unearthed potential theraï¿¾peutic targets described for other pathological conditions,
and also confirmed expression of several neuronal genes in
this cell type. For example, progranulin (also called granulin
or PC derived growth factor) was expressed equally in the cell
lines and primary HSCs, and is a novel growth factor induced
in cutaneous wound healing.40 Both LX-1 and LX-2 lines
display increased expression of survivin. This molecule
belongs to a family of genes known as inhibitors of apoptosis,
and has also been implicated in the control of mitosis and
regulation of smooth muscle cell biology in vascular
injury.41 42 Expression of follistatin-like 1 (FSTL1, FRP,
TSC-36) by stellate cells is intriguing as the protein that it
shares likeness to (follistatin) has been shown to enhance
liver regeneration and also has antifibrotic effects on
pancreatic stellate cells.43â€“45
Current antifibrotic drug development focuses on target
gene identification using array technologies, and validation
of lead compounds using high throughput analysis in cell
based assays. Human rather than rodent cells are absolutely
essential for such approaches, and the availability of cell lines
that faithfully maintain the in vivo phenotype are a vital
component. The LX-1 and LX-2 lines represent such reagents,
and the LX-2 line in particular, with its high transfectability
and ability to withstand serum free conditions, provide
important new tools in the elucidation of stellate cell biology
and the discovery of antifibrotic therapies.
Table 3 Differential gene expression by LX-1 and LX-2
cell lines compared with primary hepatic stellate cells
(HSCs): genes differentially expressed only in LX-2
compared with primary HSCs
q NM_007085 Follistatin-like 1 (FSTL1)
q NM_004526 Minichromosome maintenance deficient 2
q NM_000916 Oxytocin receptor (OXTR)
q NM_016139 Unknown
Q AI207579 Unknown
Q AA708326 Unknown
Q AY027862 Mammalian ependymin related protein 1 (MERP1)
Q NM_030777 Solute carrier family 2 (facilitated glucose
transporter)
Q NM_002705 Periplakin (PPL)
Q NM_007361 Nidogen 2 (NID2)
See footnote to table 1.
Table 4 Expression of neural genes by primary human
stellate cells and LX-1 and LX-2 cell lines
NM_000681 Adrenergic alpha 2a receptor (ADRA2A)
NM_004886 Amyloid beta (a4) binding protein
NM_006317 Brain acid soluble protein (BASP1)
NM_012109 Brain specific membrane anchored protein (BSMAP)
NM_014171 Cript (postsynaptic protein)
NM_000099 Cystatin C
NM_020806 Gephyrin (postsynaptic protein) (GPHN)
NM_004124 Glia maturation factor beta
NM_002499 Neogenin (NEO1)
NM_016592 Neuroendocrine secretory protein 55 (NESP55)
NM_013962 Neuregulin 1 (NRG1)
NM_015678 Neurobeachin (NBEA)
NM_006176 Neurogranin (NRGN)
NM_003717 Neuropeptide FF amide peptide precursor (NPFF)
NM_003619 Neurotrypsin (PRSS12)
NM_002545 Opioid binding protein (OPCML)
NM_012486 Presenilin 2 (PSEN2)
NM_000311 Prion protein (P27â€“30)
NM_021947 Serine racemase (SRR)
NM_000865 Serotonin receptor 1E (HTR1E)
NM_014232 Synaptobrevin 2
NM_007286 Synaptopodin
NM_006754 Synaptophysin-like protein (SYPL)
150 Xu, Hui, Albanis, et al
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

ACKNOWLEDGEMENTS
This work was supported by grants from the NIH to SLF (DK37340
and DK56621) and WB (DK068437), the US Department of Defense
to WB (DOD BC031116), the Artzt Family Primary Biliary Cirrhosis
Program, the Feld Fibrosis Fund, and an American Liver Foundation
Liver Scholar Award to FE. Technical assistance from Michael
Cooreman and Jose Walewski is gratefully acknowledged.
Authorsâ€™ affiliations
.....................
L Xu*, A Y Hui`, E Albanis, M J Arthur1, S L Friedman, F J Eng, Division
of Liver Diseases, Department of Medicine, Mount Sinai School of
Medicine, New York, NY, USA
S M Oâ€™Byrne, Department of Medicine, Columbia University, New York,
NY, USA
W S Blaner, Institute of Human Nutrition, Columbia University, New
York, NY, USA
P Mukherjee, Institute for Computational Biomedicine, Weill Medical
College of Cornell University, New York, NY, USA
Conflict of interest: None declared.
Present addresses: *Shanghai University of TCM, Institute of Liver
Diseases, Shuguang Hospital, Shanghai, China, 200032; `The Chinese
University of Hong Kong, Department of Medicine and Therapeutics,
Prince of Wales Hospital, Shatin, Hong Kong; 1Office of the Dean,
University of Southampton, Southampton, UK
REFERENCES
1 Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular
response to tissue injury. J Biol Chem 2000;275:2247â€“50.
2 Schuppan D, Ruehl M, Somasundaram R, et al. Matrix as modulator of stellate
cell and hepatic fibrogenesis. Semin Liver Dis 2001;21:351â€“72.
3 Rockey DC. Hepatic blood flow regulation by stellate cells in normal and
injured liver. Semin Liver Dis 2001;21:337â€“50.
4 Friedman SL, Roll FJ, Boyles J, et al. Maintenance of differentiated phenotype
of cultured rat hepatic lipocytes by basement membrane matrix. J Biol Chem
1989;264:10756â€“62.
5 Schnabl B, Choi YH, Olsen JC, et al. Immortal activated human hepatic stellate
cells generated by ectopic telomerase expression. Lab Invest
2002;82:323â€“33.
6 Olaso E, Ikeda K, Eng FJ, et al. DDR2 receptor promotes MMP-2-mediated
proliferation and invasion by hepatic stellate cells. J Clin Invest
2001;108:1369â€“78.
7 Friedman SL, Rockey DC, McGuire RF, et al. Isolated hepatic lipocytes and
Kupffer cells from normal human liver: morphological and functional
characteristics in primary culture. Hepatology 1992;15:234â€“43.
8 Olaso E, Santisteban A, Bidaurrazaga J, et al. Tumor-dependent activation of
rodent hepatic stellate cells during experimental melanoma metastasis.
Hepatology 1997;26:634â€“42.
9 Friedman SL, Arthur MJ. Activation of cultured rat hepatic lipocytes by Kupffer
cell conditioned medium. Direct enhancement of matrix synthesis and
stimulation of cell proliferation via induction of platelet-derived growth factor
receptors. J Clin Invest 1989;84:1780â€“5.
10 Yamada M, Blaner WS, Soprano DR, et al. Biochemical characteristics of
isolated rat liver stellate cells. Hepatology 1987;7:1224â€“9.
11 Ramakrishnan R, Dorris D, Lublinsky A, et al. An assessment of Motorola
CodeLink microarray performance for gene expression profiling applications.
Nucleic Acids Res 2002;30:e30.
12 Dorris DR, Nguyen A, Gieser L, et al. Oligodeoxyribonucleotide probe
accessibility on a three-dimensional DNA microarray surface and the effect of
hybridization time on the accuracy of expression ratios. BMC Biotechnol
2003;3:6.
13 Colantuoni C, Henry G, Zeger S, et al. SNOMAD (Standardization and
NOrmalization of MicroArray Data): web-accessible gene expression data
analysis. Bioinformatics 2002;18:1540â€“1.
14 Ali SH, DeCaprio JA. Cellular transformation by SV40 large T antigen:
interaction with host proteins. Semin Cancer Biol 2001;11:15â€“23.
15 Wong L, Yamasaki G, Johnson RJ, et al. Induction of beta-platelet-derived
growth factor receptor in rat hepatic lipocytes during cellular activation in vivo
and in culture. J Clin Invest 1994;94:1563â€“9.
16 Ikeda K, Wang LH, Torres R, et al. Discoidin domain receptor 2 interacts with
Src and Shc following its activation by type I collagen. J Biol Chem
2002;277:19206â€“12.
17 Honda H, Ikejima K, Hirose M, et al. Leptin is required for fibrogenic
responses induced by thioacetamide in the murine liver. Hepatology
2002;36:12â€“21.
18 Ikejima K, Takei Y, Honda H, et al. Leptin receptor-mediated signaling
regulates hepatic fibrogenesis and remodeling of extracellular matrix in the
rat. Gastroenterology 2002;122:1399â€“410.
19 Saxena NK, Ikeda K, Rockey DC, et al. Leptin in hepatic fibrosis: evidence for
increased collagen production in stellate cells and lean littermates of ob/ob
mice. Hepatology 2002;35:762â€“71.
20 Iredale JP. Stellate cell behavior during resolution of liver injury. Semin Liver
Dis 2001;21:427â€“36.
21 Arthur MJ, Friedman SL, Roll FJ, et al. Lipocytes from normal rat liver release a
neutral metalloproteinase that degrades basement membrane (type IV)
collagen. J Clin Invest 1989;84:1076â€“85.
22 Cao Q, Mak KM, Ren C, et al. Leptin stimulates tissue inhibitor of
metalloproteinase-1 in human hepatic stellate cells: Respective roles of the
JAK/STAT and JAK-mediated H2O2 dependent MAPK pathways. J Biol Chem
2004;279:4292â€“304.
23 Hendershot LM, Bulleid NJ. Protein-specific chaperones: the role of hsp47
begins to gel. Curr Biol 2000;10:R912â€“15.
24 Hellerbrand C, Jobin C, Licato LL, et al. Cytokines induce NF-kappaB in
activated but not in quiescent rat hepatic stellate cells. Am J Physiol
1998;275:G269â€“78.
25 Gao R, McCormick CJ, Arthur MJ, et al. High efficiency gene transfer into
cultured primary rat and human hepatic stellate cells using baculovirus
vectors. Liver 2002;22:15â€“22.
26 Vogel S, Piantedosi R, Frank J, et al. An immortalized rat liver stellate cell line
(HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid
Res 2000;41:882â€“93.
27 Cassiman D, Denef C, Desmet VJ, et al. Human and rat hepatic stellate cells
express neurotrophins and neurotrophin receptors. Hepatology
2001;33:148â€“58.
28 Cassiman D, Libbrecht L, Desmet V, et al. Hepatic stellate cell/myofibroblast
subpopulations in fibrotic human and rat livers. J Hepatol 2002;36:200â€“9.
29 Levy MT, McCaughan GW, Abbott CA, et al. Fibroblast activation protein: a
cell surface dipeptidyl peptidase and gelatinase expressed by stellate cells at
the tissue remodelling interface in human cirrhosis. Hepatology
1999;29:1768â€“78.
30 Taimr P, Higuchi H, Kocova E, et al. Activated stellate cells express the TRAIL
receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis.
Hepatology 2003;37:87â€“95.
31 Nakatsukasa H, Nagy P, Evarts RP, et al. Cellular distribution of transforming
growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon
tetrachloride-induced rat liver fibrosis. J Clin Invest 1990;85:1833â€“43.
32 Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha
in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med
1991;324:933â€“40.
33 Geerts A, Lazou JM, De Bleser P, et al. Tissue distribution, quantitation and
proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat
liver. Hepatology 1991;13:1193â€“202.
34 Zou Z, Ekataksin W, Wake K. Zonal and regional differences identified from
precision mapping of vitamin A-storing lipid droplets of the hepatic stellate
cells in pig liver: a novel concept of addressing the intralobular area of
heterogeneity. Hepatology 1998;27:1098â€“108.
35 Wake K, Sato T. Intralobular heterogeneity of perisinusoidal stellate cells in
porcine liver. Cell Tissue Res 1993;273:227â€“37.
36 Murakami K, Abe T, Miyazawa M, et al. Establishment of a new human cell
line, LI90, exhibiting characteristics of hepatic Ito (fat-storing) cells. Lab Invest
1995;72:731â€“9.
37 Weill FX, Blazejewski S, Blanc JF, et al. Characterization of a new human liver
myofibroblast cell line: transcriptional regulation of plasminogen activator
inhibitor type I by transforming growth factor beta 1. Lab Invest
1997;77:63â€“70.
38 Yang C, Zeisberg M, Mosterman B, et al. Liver fibrosis: Insights into migration
of hepatic stellate cells in response to extracellular matrix and growth factors.
Gastroenterology 2003;124:147â€“59.
39 Murphy FR, Issa R, Zhou X, et al. Inhibition of apoptosis of activated hepatic
stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects
on matrix metalloproteinase inhibition: implications for reversibility of liver
fibrosis. J Biol Chem 2002;277:11069â€“76.
40 He Z, Ong CH, Halper J, et al. Progranulin is a mediator of the wound
response. Nat Med 2003;9:225â€“9.
41 Oâ€™Driscoll L, Linehan R, Clynes M. Survivin: role in normal cells and in
pathological conditions. Curr Cancer Drug Targets 2003;3:131â€“52.
42 Blanc-Brude OP, Yu J, Simosa H, et al. Inhibitor of apoptosis protein survivin
regulates vascular injury. Nat Med 2002;8:987â€“94.
43 Kogure K, Zhang YQ, Shibata H, et al. Immediate onset of DNA synthesis in
remnant rat liver after 90% hepatectomy by an administration of follistatin.
J Hepatol 1998;29:977â€“84.
44 Takabe K, Wang L, Leal AM, et al. Adenovirus-mediated overexpression of
follistatin enlarges intact liver of adult rats. Hepatology 2003;38:1107â€“15.
45 Ohnishi N, Miyata T, Ohnishi H, et al. Activin A is an autocrine activator of rat
pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic
fibrosis. Gut 2003;52:1487â€“93.
Human HSC lines, LX-1 and LX-2 151
www.gutjnl.com
Protected by copyright, including for uses related to text and data mining, AI training, and similar technologies. 
. Technical Services Serials
at New York University, Serials Bobst Library on November 3, 2025 http://gut.bmj.com/ Downloaded from 10 December 2004. 10.1136/gut.2004.042127 on Gut: first published as 

